Skip to main content
Erschienen in: Osteoporosis International 7/2020

30.01.2020 | Review

A systematic review of the indirect and social costs studies in fragility fractures

verfasst von: M. Ruiz-Adame, M. Correa

Erschienen in: Osteoporosis International | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Fragility fractures (FF) are the main clinical consequence of osteoporosis. FF lead to a loss in quality of life (QL), increased dependency and higher costs due to loss of productivity. Despite this, very few studies have been performed about the indirect or social costs of FF. The objective of this review was to systematically synthesize published evidence regarding indirect costs of FF. We conducted a systematic literature review of empirical studies published as peer review papers between 1998 and 2019. A total of 295 papers were found about costs and osteoporosis. After an iterative process, only 16 papers fit the criteria of selection. Despite the important consequences for QL, only seven studies have included research of the issue and only one about dependency. Treatments are cost-effective, but adherence is low. Multiple fractures, older age and low socioeconomic profile imply higher costs. Most studies are performed using the human capital methodology. The main two variables are loss of productivity and absenteeism. Most of the people included in the samples are out of the active population. Those studies that include a follow-up period vary in a range between 3 months and 2 years. Depending on sample and methodology, the indirect costs (IC) are between 2 and 50%. The direct costs associated with FF generally far outweigh the IC. There is a lack of studies about the effects of treatments and adherence and about the dependency system. The changing role of women in coming generations will increase indirect costs.
Literatur
1.
Zurück zum Zitat Consensus development conference (1993) Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94(6):646–650CrossRef Consensus development conference (1993) Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94(6):646–650CrossRef
2.
Zurück zum Zitat Sozen T, Ozisik L, Calik Basaran N (2017) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46–56PubMedCrossRef Sozen T, Ozisik L, Calik Basaran N (2017) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46–56PubMedCrossRef
3.
Zurück zum Zitat World Health Organization. Who Scientific Group on the Assessment of Osteoporosis At Primary Health. World Health. 2007;May(May 2004):1–13 World Health Organization. Who Scientific Group on the Assessment of Osteoporosis At Primary Health. World Health. 2007;May(May 2004):1–13
4.
Zurück zum Zitat Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381PubMedPubMedCentralCrossRef Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O’Malley CD (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182PubMedCrossRef Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O’Malley CD (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182PubMedCrossRef
6.
Zurück zum Zitat Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: Medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1–2) Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: Medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1–2)
7.
Zurück zum Zitat World_Health_Organization. Guidelines for preclinical evaluation and clinical trials in osteoporosis. World Health Organization; 1998 World_Health_Organization. Guidelines for preclinical evaluation and clinical trials in osteoporosis. World Health Organization; 1998
8.
Zurück zum Zitat Kanis JA (2002) Osteoporosis III: Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 359(9321):1929–1936PubMedCrossRef Kanis JA (2002) Osteoporosis III: Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 359(9321):1929–1936PubMedCrossRef
9.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Borgstrom F, Johansson H, De Laet C, Jönsson B (2005) Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 16(1):6–14PubMedCrossRef Kanis JA, Johnell O, Oden A, Borgstrom F, Johansson H, De Laet C, Jönsson B (2005) Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 16(1):6–14PubMedCrossRef
10.
Zurück zum Zitat Pisani P, Renna MD, Conversano F, Casciaro E, Di Paola M, Quarta E, Muratore M, Casciaro S (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop 7(3):171–181PubMedPubMedCentralCrossRef Pisani P, Renna MD, Conversano F, Casciaro E, Di Paola M, Quarta E, Muratore M, Casciaro S (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop 7(3):171–181PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Abrahamsen B, Van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650PubMedCrossRef Abrahamsen B, Van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650PubMedCrossRef
12.
Zurück zum Zitat Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15(10):767–778PubMedCrossRef Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15(10):767–778PubMedCrossRef
13.
Zurück zum Zitat Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35(5):293–305CrossRefPubMed Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35(5):293–305CrossRefPubMed
14.
Zurück zum Zitat Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239–2256PubMedPubMedCentralCrossRef Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239–2256PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G (2017) Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int 28(5):1531–1542PubMedCrossRef Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G (2017) Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int 28(5):1531–1542PubMedCrossRef
16.
Zurück zum Zitat Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22(5):1277–1288PubMedPubMedCentralCrossRef Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22(5):1277–1288PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733CrossRefPubMed Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733CrossRefPubMed
18.
Zurück zum Zitat Cummings SR, Melton LJ (2002) Epidemiology and consequences of osteoporotic fractures. Lancet. 359:1761–1767PubMedCrossRef Cummings SR, Melton LJ (2002) Epidemiology and consequences of osteoporotic fractures. Lancet. 359:1761–1767PubMedCrossRef
19.
Zurück zum Zitat Åkesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24(8):2135–2152PubMedPubMedCentralCrossRef Åkesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24(8):2135–2152PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27(10):2039–2046PubMedCrossRef Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27(10):2039–2046PubMedCrossRef
21.
Zurück zum Zitat Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M (2010) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–739CrossRef Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M (2010) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–739CrossRef
22.
Zurück zum Zitat Lindsay R, Cooper C, Hanley DA, Barton I, Broy SB, Flowers K (2001) Risk of new vertebral fracture. J Am Med Assoc 285(3):7–10CrossRef Lindsay R, Cooper C, Hanley DA, Barton I, Broy SB, Flowers K (2001) Risk of new vertebral fracture. J Am Med Assoc 285(3):7–10CrossRef
23.
Zurück zum Zitat Johansson H, Siggeirsdóttir K, Harvey NC, Odén A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA (2017) Imminent risk of fracture after fracture. Osteoporos Int 28(3):775–780PubMedCrossRef Johansson H, Siggeirsdóttir K, Harvey NC, Odén A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA (2017) Imminent risk of fracture after fracture. Osteoporos Int 28(3):775–780PubMedCrossRef
24.
Zurück zum Zitat Ray NF, Chan JK, Thamer M, Melton LJ (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12(1):24–35PubMedCrossRef Ray NF, Chan JK, Thamer M, Melton LJ (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12(1):24–35PubMedCrossRef
25.
Zurück zum Zitat Hoerger TJ, Downs KE, Lakshmanan MC, Lindrooth RC, Plouffe LEO Jr, Wendling B, West SL, Ohsfeldt RL (1999) Healthcare use among US women aged 45 and older: total costs and costs for selected postmenopausal health risks. J Womens Health Gend Based Med 8(8):1077–1089PubMedCrossRef Hoerger TJ, Downs KE, Lakshmanan MC, Lindrooth RC, Plouffe LEO Jr, Wendling B, West SL, Ohsfeldt RL (1999) Healthcare use among US women aged 45 and older: total costs and costs for selected postmenopausal health risks. J Womens Health Gend Based Med 8(8):1077–1089PubMedCrossRef
26.
Zurück zum Zitat Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone. 15(4):377–386PubMedCrossRef Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone. 15(4):377–386PubMedCrossRef
27.
Zurück zum Zitat Phillips S, Fox N, Jacobs J, Wright WE (1988) The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone. 9(5):271–279PubMedCrossRef Phillips S, Fox N, Jacobs J, Wright WE (1988) The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone. 9(5):271–279PubMedCrossRef
28.
Zurück zum Zitat Johnell O (1997) The socioeconomic burden of fractures today and in the 21st century - the American journal of medicine. Am J Med 103(2):S20–S26CrossRef Johnell O (1997) The socioeconomic burden of fractures today and in the 21st century - the American journal of medicine. Am J Med 103(2):S20–S26CrossRef
29.
Zurück zum Zitat Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465–475PubMedCrossRef Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465–475PubMedCrossRef
30.
Zurück zum Zitat Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 6(1–2):59–155PubMedCrossRef Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 6(1–2):59–155PubMedCrossRef
31.
Zurück zum Zitat Eekman DA, Ter Wee MM, Coupé VMH, Erisek-Demirtas S, Kramer MH, Lems WF (2014) Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation. Osteoporos Int 25(1):195–204PubMedCrossRef Eekman DA, Ter Wee MM, Coupé VMH, Erisek-Demirtas S, Kramer MH, Lems WF (2014) Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation. Osteoporos Int 25(1):195–204PubMedCrossRef
32.
Zurück zum Zitat Fujiwara S, Zhao X, Teoh C, Jaffe DH, Taguchi Y (2019) Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs. J Bone Miner Metab 37(2):307–318PubMedCrossRef Fujiwara S, Zhao X, Teoh C, Jaffe DH, Taguchi Y (2019) Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs. J Bone Miner Metab 37(2):307–318PubMedCrossRef
33.
Zurück zum Zitat Borgström F, Sobocki P, Ström O, Jönsson B (2007) The societal burden of osteoporosis in Sweden. Bone. 40(6):1602–1609PubMedCrossRef Borgström F, Sobocki P, Ström O, Jönsson B (2007) The societal burden of osteoporosis in Sweden. Bone. 40(6):1602–1609PubMedCrossRef
35.
Zurück zum Zitat Urrútia G, Bonfilll X (2013) La declaración prisma: Un paso adelante en la mejora de las publicaciones de la revista Española de salud pública. Rev Esp Salud Publica 87(2):99–102PubMedCrossRef Urrútia G, Bonfilll X (2013) La declaración prisma: Un paso adelante en la mejora de las publicaciones de la revista Española de salud pública. Rev Esp Salud Publica 87(2):99–102PubMedCrossRef
36.
Zurück zum Zitat Ng CS, Lau TC, Ko Y (2017) Cost of osteoporotic fractures in Singapore. Value Heal Reg Issues 12:27–35CrossRef Ng CS, Lau TC, Ko Y (2017) Cost of osteoporotic fractures in Singapore. Value Heal Reg Issues 12:27–35CrossRef
37.
38.
Zurück zum Zitat Marques A, Lourenço, da Silva JAP (2015) The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality. Osteoporos Int 26(11):2623–2630PubMedCrossRef Marques A, Lourenço, da Silva JAP (2015) The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality. Osteoporos Int 26(11):2623–2630PubMedCrossRef
39.
Zurück zum Zitat Qu B, Ma Y, Yan M, Wu HH, Fan L, Liao DF, Pan XM, Hong Z (2014) The economic burden of fracture patients with osteoporosis in western China. Osteoporos Int 25(7):1853–1860PubMedCrossRef Qu B, Ma Y, Yan M, Wu HH, Fan L, Liao DF, Pan XM, Hong Z (2014) The economic burden of fracture patients with osteoporosis in western China. Osteoporos Int 25(7):1853–1860PubMedCrossRef
40.
Zurück zum Zitat Bleibler F, Rapp K, Jaensch A, Becker C, König HH (2014) Expected lifetime numbers and costs of fractures in postmenopausal women with and without osteoporosis in Germany: a discrete event simulation model. BMC Health Serv Res 14(1):1–18CrossRef Bleibler F, Rapp K, Jaensch A, Becker C, König HH (2014) Expected lifetime numbers and costs of fractures in postmenopausal women with and without osteoporosis in Germany: a discrete event simulation model. BMC Health Serv Res 14(1):1–18CrossRef
41.
Zurück zum Zitat Bleibler F, Konnopka A, Benzinger P, Rapp K, König HH (2013) The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany - a demographic simulation model. Osteoporos Int 24(3):835–847PubMedCrossRef Bleibler F, Konnopka A, Benzinger P, Rapp K, König HH (2013) The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany - a demographic simulation model. Osteoporos Int 24(3):835–847PubMedCrossRef
43.
Zurück zum Zitat Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, Papaioannou A, Bessette L, Brown JP, Goeree R (2012) The burden of illness of osteoporosis in Canada. Osteoporos Int 23(11):2591–2600PubMedPubMedCentralCrossRef Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, Papaioannou A, Bessette L, Brown JP, Goeree R (2012) The burden of illness of osteoporosis in Canada. Osteoporos Int 23(11):2591–2600PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Dimai HP, Redlich K, Schneider H, Siebert U, Viernstein H, Mahlich J (2012) Direct and indirect costs of fractures due to osteoporosis in Austria. Gesundheitswesen. 74(10):90–98 Dimai HP, Redlich K, Schneider H, Siebert U, Viernstein H, Mahlich J (2012) Direct and indirect costs of fractures due to osteoporosis in Austria. Gesundheitswesen. 74(10):90–98
46.
Zurück zum Zitat Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics. 28(5):395–409PubMedCrossRef Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics. 28(5):395–409PubMedCrossRef
47.
Zurück zum Zitat Konnopka A, Jerusel N, König HH (2009) The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050. Osteoporos Int 20(7):1117–1129PubMedCrossRef Konnopka A, Jerusel N, König HH (2009) The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050. Osteoporos Int 20(7):1117–1129PubMedCrossRef
48.
Zurück zum Zitat Ström O, Borgström F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, Abdon P, Ornstein E, Ceder L, Thorngren KG, Sernbo I, Jönsson B (2008) Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden. Acta Orthop 79(2):269–280PubMedCrossRef Ström O, Borgström F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, Abdon P, Ornstein E, Ceder L, Thorngren KG, Sernbo I, Jönsson B (2008) Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden. Acta Orthop 79(2):269–280PubMedCrossRef
49.
Zurück zum Zitat Dzajkovska B, Wertheimer AI, Mrhar A (2007) The burden-of-illness study on osteoporosis in the Slovenian female population. Pharm World Sci 29(4):404–411PubMedCrossRef Dzajkovska B, Wertheimer AI, Mrhar A (2007) The burden-of-illness study on osteoporosis in the Slovenian female population. Pharm World Sci 29(4):404–411PubMedCrossRef
52.
Zurück zum Zitat Fox C, Edwards MH, Dennison EM, Cooper C (2015) Personal and societal burden of osteoporotic fractures. Clin Rev Bone Miner Metab 13(2):53–60CrossRef Fox C, Edwards MH, Dennison EM, Cooper C (2015) Personal and societal burden of osteoporotic fractures. Clin Rev Bone Miner Metab 13(2):53–60CrossRef
53.
Zurück zum Zitat Boonen S, Singer AJ (2008) Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I. Curr Med Res Opin 24(6):1781–1788PubMedCrossRef Boonen S, Singer AJ (2008) Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I. Curr Med Res Opin 24(6):1781–1788PubMedCrossRef
Metadaten
Titel
A systematic review of the indirect and social costs studies in fragility fractures
verfasst von
M. Ruiz-Adame
M. Correa
Publikationsdatum
30.01.2020
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 7/2020
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-020-05319-x

Weitere Artikel der Ausgabe 7/2020

Osteoporosis International 7/2020 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.